Continuing difficulties in interpreting CNV data: lessons from a genome-wide CNV association study of Australian HNPCC/lynch syndrome patients

BMC Medical Genomics

Rodney J Scott¹  Allan Spigelman³  Cliff Meldrum¹  Amy L Masson⁴  Desma M Grice⁵  John Attia²  Mark McEvoy²  Tiffany-Jane Evans⁴  Elizabeth G Holliday²  Bente A Talseth-Palmer⁴ 

[1] Hunter Area Pathology Service, Hunter New England Area Health, New Lambton Heights, NSW, Australia;School of Medicine and Public Health, University of Newcastle, Newcastle, NSW, Australia;Hunter New England Family Cancer Service, Newcastle, NSW, Australia;Hunter Medical Research Institute, John Hunter Hospital, Newcastle, NSW, Australia;Food and Nutritional Sciences, Preventative Health Flagship & CSIRO, North Ryde, NSW, Australia

关键词: CNV burden;    CNVs;    SNP arrays;    Lynch syndrome;    HNPCC;   

Others  :  1092526
DOI  :  10.1186/1755-8794-6-10

 received in 2012-08-27, accepted in 2013-03-18,  发布年份 2013

【 摘 要 】

Background

Hereditary non-polyposis colorectal cancer (HNPCC)/Lynch syndrome (LS) is a cancer syndrome characterised by early-onset epithelial cancers, especially colorectal cancer (CRC) and endometrial cancer. The aim of the current study was to use SNP-array technology to identify genomic aberrations which could contribute to the increased risk of cancer in HNPCC/LS patients.

Methods

Individuals diagnosed with HNPCC/LS (100) and healthy controls (384) were genotyped using the Illumina Human610-Quad SNP-arrays. Copy number variation (CNV) calling and association analyses were performed using Nexus software, with significant results validated using QuantiSNP. TaqMan Copy-Number assays were used for verification of CNVs showing significant association with HNPCC/LS identified by both software programs.

Results

We detected copy number (CN) gains associated with HNPCC/LS status on chromosome 7q11.21 (28% cases and 0% controls, Nexus; p = 3.60E-20 and QuantiSNP; p < 1.00E-16) and 16p11.2 (46% in cases, while a CN loss was observed in 23% of controls, Nexus; p = 4.93E-21 and QuantiSNP; p = 5.00E-06) via in silico analyses. TaqMan Copy-Number assay was used for validation of CNVs showing significant association with HNPCC/LS. In addition, CNV burden (total CNV length, average CNV length and number of observed CNV events) was significantly greater in cases compared to controls.

Conclusion

A greater CNV burden was identified in HNPCC/LS cases compared to controls supporting the notion of higher genomic instability in these patients. One intergenic locus on chromosome 7q11.21 is possibly associated with HNPCC/LS and deserves further investigation. The results from this study highlight the complexities of fluorescent based CNV analyses. The inefficiency of both CNV detection methods to reproducibly detect observed CNVs demonstrates the need for sequence data to be considered alongside intensity data to avoid false positive results.

【 授权许可】

   
2013 Talseth-Palmer et al.; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

【 参考文献 】

• [1]Dhami P, Coffey AJ, Abbs S, Vermeesch JR, Dumanski JP, Woodward KJ, Andrews RM, Langford C, Vetrie D: Exon array CGH: detection of copy-number changes at the resolution of individual exons in the human genome. Am J Hum Genet 2005, 76(5):750-762.
• [2]Iafrate AJ, Feuk L, Rivera MN, Listewnik ML, Donahoe PK, Qi Y, Scherer SW, Lee C: Detection of large-scale variation in the human genome. Nat Genet 2004, 36(9):949-951.
• [3]Stankiewicz P, Lupski JR: Molecular-evolutionary mechanisms for genomic disorders. Curr Opin Genet Dev 2002, 12(3):312-319.
• [4]Wilson GM, Flibotte S, Chopra V, Melnyk BL, Honer WG, Holt RA: DNA copy-number analysis in bipolar disorder and schizophrenia reveals aberrations in genes involved in glutamate signaling. Hum Mol Genet 2006, 15(5):743-749.
• [5]Talseth-Palmer B, Scott R: Genetic variation and its role in malignancy. Int J Biomed Sci 2011, 7(3):158-171.
• [6]Redon R: Global variation in copy number in the human genome. Nature 2006, 444(7118):444-454.
• [7]Feuk L, Carson AR, Scherer SW: Structural variation in the human genome. Nat Rev Genet 2006, 7(2):85-97.
• [8]Lou H, Li S, Yang Y, Kang L, Zhang X, Jin W, Wu B, Jin L, Xu S: A map of copy number variations in Chinese populations. PLoS One 2011, 6(11):e27341.
• [9]Stranger BE, Forrest MS, Dunning M, Ingle CE, Beazley C, Thorne N, Redon R, Bird CP, de Grassi A, Lee C, Tyler-Smith C, Carter N, Scherer SW, Tavare S, Deloukas P, Hurles ME, Dermitzakis ET: Relative impact of nucleotide and copy number variation on gene expression phenotypes. Science 2007, 315(5813):848-853.
• [10]Yang TL, Chen XD, Guo Y, Lei SF, Wang JT, Zhou Q, Pan F, Chen Y, Zhang ZX, Dong SS, Xu XH, Yan H, Liu X, Qiu C, Zhu XZ, Chen T, Li M, Zhang H, Zhang L, Drees BM, Hamilton JJ, Papasian CJ, Recker RR, Song XP, Cheng J, Deng HW: Genome-wide copy-number-variation study identified a susceptibility gene, UGT2B17, for osteoporosis. Am J Hum Genet 2008, 83(6):663-674.
• [11]Zhang F, Gu W, Hurles ME, Lupski JR: Copy number variation in human health, disease, and evolution. Annu Rev Genomics Hum Genet 2009, 10:451-481.
• [12]Thean LF, Loi C, Ho KS, Koh PK, Eu KW, Cheah PY: Genome-wide scan identifies a copy number variable region at 3q26 that regulates PPM1L in APC mutation-negative familial colorectal cancer patients. Genes Chromosomes Cancer 2010, 49(2):99-106.
• [13]Perry GH, Dominy NJ, Claw KG, Lee AS, Fiegler H, Redon R, Werner J, Villanea FA, Mountain JL, Misra R, Carter NP, Lee C, Stone AC: Diet and the evolution of human amylase gene copy number variation. Nat Genet 2007, 39(10):1256-1260.
• [14]Almal SH, Padh H: Implications of gene copy-number variation in health and diseases. J Hum Genet 2012, 57(1):6-13.
• [15]Bronstad I, Wolff AS, Lovas K, Knappskog PM, Husebye ES: Genome-wide copy number variation (CNV) in patients with autoimmune Addison's disease. BMC Med Genet 2011, 12:111. BioMed Central Full Text
• [16]Hai R, Pei YF, Shen H, Zhang L, Liu XG, Lin Y, Ran S, Pan F, Tan LJ, Lei SF, Yang TL, Zhang Y, Zhu XZ, Zhao LJ, Deng HW: Genome-wide association study of copy number variation identified gremlin1 as a candidate gene for lean body mass. J Hum Genet 2012, 57(1):33-37.
• [17]Jiang Q, Ho YY, Hao L, Nichols Berrios C, Chakravarti A: Copy number variants in candidate genes are genetic modifiers of Hirschsprung disease. PLoS One 2011, 6(6):e21219.
• [18]Craddock N: Genome-wide association study of CNVs in 16,000 cases of eight common diseases and 3,000 shared controls. Nature 2010, 464(7289):713-720.
• [19]Buizer-Voskamp JE, Muntjewerff JW, Strengman E, Sabatti C, Stefansson H, Vorstman JA, Ophoff RA: Genome-wide analysis shows increased frequency of copy number variation deletions in Dutch schizophrenia patients. Biol Psychiatry 2011, 70(7):655-662.
• [20]Dauber A, Yu Y, Turchin MC, Chiang CW, Meng YA, Demerath EW, Patel SR, Rich SS, Rotter JI, Schreiner PJ, Wilson JG, Shen Y, Wu BL, Hirschhorn JN: Genome-wide association of copy-number variation reveals an association between short stature and the presence of low-frequency genomic deletions. Am J Hum Genet 2011, 89(6):751-759.
• [21]Felekkis K, Voskarides K, Dweep H, Sticht C, Gretz N, Deltas C: Increased number of microRNA target sites in genes encoded in CNV regions. Evidence for an evolutionary genomic interaction. Mol Biol Evol 2011, 28(9):2421-2424.
• [22]Consortium TISISC: Rare chromosomal deletions and duplications increase risk of schizophrenia. Nature 2008, 455(7210):237-241.
• [23]Pinto D: Functional impact of global rare copy number variation in autism spectrum disorders. Nature 2010, 466(7304):368-372.
• [24]Girirajan S, Brkanac Z, Coe BP, Baker C, Vives L, Vu TH, Shafer N, Bernier R, Ferrero GB, Silengo M, Warren ST, Moreno CS, Fichera M, Romano C, Raskind WH, Eichler EE: Relative burden of large CNVs on a range of neurodevelopmental phenotypes. PLoS Genet 2011, 7(11):e1002334.
• [25]Kawamura Y, Otowa T, Koike A, Sugaya N, Yoshida E, Yasuda S, Inoue K, Takei K, Konishi Y, Tanii H, Shimada T, Tochigi M, Kakiuchi C, Umekage T, Liu X, Nishida N, Tokunaga K, Kuwano R, Okazaki Y, Kaiya H, Sasaki T: A genome-wide CNV association study on panic disorder in a Japanese population. J Hum Genet 2011, 56(12):852-856.
• [26]Ghoussaini M: Genome-wide association analysis identifies three new breast cancer susceptibility loci. Nat Genet 2012, 44(3):312-318.
• [27]Ku CS, Loy EY, Pawitan Y, Chia KS: The pursuit of genome-wide association studies: where are we now? J Hum Genet 2010, 55(4):195-206.
• [28]Houlston RS: Meta-analysis of genome-wide association data identifies four new susceptibility loci for colorectal cancer. Nat Genet 2008, 40(12):1426-1435.
• [29]Houlston RS: Meta-analysis of three genome-wide association studies identifies susceptibility loci for colorectal cancer at 1q41, 3q26.2, 12q13.13 and 20q13.33. Nat Genet 2010, 42(11):973-977.
• [30]Broderick P, Carvajal-Carmona L, Pittman AM, Webb E, Howarth K, Rowan A, Lubbe S, Spain S, Sullivan K, Fielding S, Jaeger E, Vijayakrishnan J, Kemp Z, Gorman M, Chandler I, Papaemmanuil E, Penegar S, Wood W, Sellick G, Qureshi M, Teixeira A, Domingo E, Barclay E, Martin L, Sieber O, Kerr D, Gray R, Peto J, Cazier JB, Tomlinson I, Houlston RS: A genome-wide association study shows that common alleles of SMAD7 influence colorectal cancer risk. Nat Genet 2007, 39(11):1315-1317.
• [31]Tenesa A: Genome-wide association scan identifies a colorectal cancer susceptibility locus on 11q23 and replicates risk loci at 8q24 and 18q21. Nat Genet 2008, 40(5):631-637.
• [32]Tomlinson IP: A genome-wide association study identifies colorectal cancer susceptibility loci on chromosomes 10p14 and 8q23.3. Nat Genet 2008, 40(5):623-630.
• [33]Cooper GM, Mefford HC: Detection of copy number variation using SNP genotyping. Methods Mol Biol 2011, 767:243-252.
• [34]Dellinger AE, Saw SM, Goh LK, Seielstad M, Young TL, Li YJ: Comparative analyses of seven algorithms for copy number variant identification from single nucleotide polymorphism arrays. Nucleic Acids Res 2010, 38(9):e105.
• [35]Berg M, Agesen TH, Thiis-Evensen E, Merok MA, Teixeira MR, Vatn MH, Nesbakken A, Skotheim RI, Lothe RA: Distinct high resolution genome profiles of early onset and late onset colorectal cancer integrated with gene expression data identify candidate susceptibility loci. Mol Cancer 2010, 9:100. BioMed Central Full Text
• [36]Fishel R, Lescoe MK, Rao MR, Copeland NG, Jenkins NA, Garber J, Kane M, Kolodner R: The human mutator gene homolog MSH2 and its association with hereditary nonpolyposis colon cancer. Cell 1993, 75(5):1027-1038.
• [37]Bronner CE, Baker SM, Morrison PT, Warren G, Smith LG, Lescoe MK, Kane M, Earabino C, Lipford J, Lindblom A: Mutation in the DNA mismatch repair gene homologue hMLH1 is associated with hereditary non-polyposis colon cancer. Nature 1994, 368(6468):258-261.
• [38]Peltomaki P, Vasen HF: Mutations predisposing to hereditary nonpolyposis colorectal cancer: database and results of a collaborative study. The International Collaborative Group on Hereditary Nonpolyposis Colorectal Cancer. Gastroenterology 1997, 113(4):1146-1158.
• [39]Peltomaki P: Deficient DNA mismatch repair: a common etiologic factor for colon cancer. Hum Mol Genet 2001, 10(7):735-740.
• [40]Lawes DA, SenGupta SB, Boulos PB: Pathogenesis and clinical management of hereditary non-polyposis colorectal cancer. Br J Surg 2002, 89(11):1357-1369.
• [41]Ligtenberg MJ, Kuiper RP, Chan TL, Goossens M, Hebeda KM, Voorendt M, Lee TY, Bodmer D, Hoenselaar E, Hendriks-Cornelissen SJ, Tsui WY, Kong CK, Brunner HG, van Kessel AG, Yuen ST, van Krieken JH, Leung SY, Hoogerbrugge N: Heritable somatic methylation and inactivation of MSH2 in families with Lynch syndrome due to deletion of the 3' exons of TACSTD1. Nat Genet 2009, 41(1):112-117.
• [42]Jiricny J: The multifaceted mismatch-repair system. Nat Rev Mol Cell Biol 2006, 7(5):335-346.
• [43]Vasen HF, Watson P, Mecklin JP, Lynch HT: New clinical criteria for hereditary nonpolyposis colorectal cancer (HNPCC, Lynch syndrome) proposed by the International Collaborative group on HNPCC. Gastroenterology 1999, 116(6):1453-1456.
• [44]Umar A, Boland CR, Terdiman JP, Syngal S, de la Chapelle A, Ruschoff J, Fishel R, Lindor NM, Burgart LJ, Hamelin R, Hamilton SR, Hiatt RA, Jass J, Lindblom A, Lynch HT, Peltomaki P, Ramsey SD, Rodriguez-Bigas MA, Vasen HF, Hawk ET, Barrett JC, Freedman AN, Srivastava S: Revised Bethesda Guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability. J Natl Cancer Inst 2004, 96(4):261-268.
• [45]Ku CS, Cooper DN, Wu M, Roukos DH, Pawitan Y, Soong R, Iacopetta B: Gene discovery in familial cancer syndromes by exome sequencing: prospects for the elucidation of familial colorectal cancer type X. Mod Pathol 2012, 25(8):1055-1068.
• [46]Dunlop MG: Guidance on gastrointestinal surveillance for hereditary non-polyposis colorectal cancer, familial adenomatous polypolis, juvenile polyposis, and Peutz-Jeghers syndrome. Gut 2002, 51(Suppl 5):V21-V27.
• [47]Dunlop MG, Farrington SM, Nicholl I, Aaltonen L, Petersen G, Porteous M, Carothers A: Population carrier frequency of hMSH2 and hMLH1 mutations. Br J Cancer 2000, 83(12):1643-1645.
• [48]Alarcon F, Lasset C, Carayol J, Bonadona V, Perdry H, Desseigne F, Wang Q, Bonaiti-Pellie C: Estimating cancer risk in HNPCC by the GRL method. Eur J Hum Genet 2007, 15(8):831-836.
• [49]Obermair A, Youlden DR, Young JP, Lindor NM, Baron JA, Newcomb P, Parry S, Hopper JL, Haile R, Jenkins MA: Risk of endometrial cancer for women diagnosed with HNPCC-related colorectal carcinoma. Int J Cancer 2010, 127(11):2678-2684.
• [50]Miller SA, Dykes DD, Polesky HF: A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 1988, 16(3):1215.
• [51]McEvoy M, Smith W, D'Este C, Duke J, Peel R, Schofield P, Scott R, Byles J, Henry D, Ewald B, Hancock S, Smith D, Attia J: Cohort profile: the hunter community study. Int J Epidemiol 2010, 39(16):1452-1463.
• [52]Colella S, Yau C, Taylor JM, Mirza G, Butler H, Clouston P, Bassett AS, Seller A, Holmes CC, Ragoussis J: QuantiSNP: an Objective Bayes Hidden-Markov Model to detect and accurately map copy number variation using SNP genotyping data. Nucleic Acids Res 2007, 35(6):2013-2025.
• [53]Darvishi K: Application of Nexus copy number software for CNV detection and analysis. In Current protocols in human genetics / editorial board Edited by Haines JL. 2010, 11-28. Chapter 4:Unit 4 14
• [54]Andreson R, Puurand T, Remm M: SNPmasker: automatic masking of SNPs and repeats across eukaryotic genomes. Nucleic Acids Res 2006, 34:W651-W655. Web Server issue
• [55]Jiang H, Yi M, Mu J, Zhang L, Ivens A, Klimczak LJ, Huyen Y, Stephens RM, Su XZ: Detection of genome-wide polymorphisms in the AT-rich Plasmodium falciparum genome using a high-density microarray. BMC Genomics 2008, 9:398. BioMed Central Full Text
• [56]Auer H: Expression divergence and copy number variation in the human genome. Cytogenet Genome Res 2008, 123(1–4):278-282.
• [57]Shaikh TH, Gai X, Perin JC, Glessner JT, Xie H, Murphy K, O'Hara R, Casalunovo T, Conlin LK, D'Arcy M, Frackelton EC, Geiger EA, Haldeman-Englert C, Imielinski M, Kim CE, Medne L, Annaiah K, Bradfield JP, Dabaghyan E, Eckert A, Onyiah CC, Ostapenko S, Otieno FG, Santa E, Shaner JL, Skraban R, Smith RM, Elia J, Goldmuntz E, Spinner NB, Zackai EH, Chiavacci RM, Grundmeier R, Rappaport EF, Grant SF, White PS, Hakonarson H: High-resolution mapping and analysis of copy number variations in the human genome: a data resource for clinical and research applications. Genome Res 2009, 19(9):1682-1690.
• [58]Friedrichsen DM, Stanford JL, Isaacs SD, Janer M, Chang BL, Deutsch K, Gillanders E, Kolb S, Wiley KE, Badzioch MD, Zheng SL, Walsh PC, Jarvik GP, Hood L, Trent JM, Isaacs WB, Ostrander EA, Xu J: Identification of a prostate cancer susceptibility locus on chromosome 7q11-21 in Jewish families. Proc Natl Acad Sci USA 2004, 101(7):1939-1944.
• [59]Ariza M, Llorente JL, Alvarez-Marcas C, Baragano L, Salas A, Rodriguez Prado N, Hermsen M, Suarez C, Sampedro A: Comparative genomic hybridization in primary sinonasal adenocarcinomas. Cancer 2004, 100(2):335-341.
• [60]Diosdado B, Buffart TE, Watkins R, Carvalho B, Ylstra B, Tijssen M, Bolijn AS, Lewis F, Maude K, Verbeke C, Nagtegaal ID, Grabsch H, Mulder CJ, Quirke P, Howdle P, Meijer GA: High-resolution array comparative genomic hybridization in sporadic and celiac disease-related small bowel adenocarcinomas. Clin Cancer Res 2010, 16(5):1391-1401.
• [61]Girirajan S, Eichler EE: Phenotypic variability and genetic susceptibility to genomic disorders. Hum Mol Genet 2010, 19(R2):R176-R187.
• [62]The_International_Schizophrenia_Consortium: Rare chromosomal deletions and duplications increase risk of schizophrenia. Nature 2008, 455(7210):237-241.
• [63]Magri C, Sacchetti E, Traversa M, Valsecchi P, Gardella R, Bonvicini C, Minelli A, Gennarelli M, Barlati S: New copy number variations in schizophrenia. PLoS One 2010, 5(10):e13422.
• [64]Kuiper RP, Ligtenberg MJ, Hoogerbrugge N, Geurts Van Kessel A: Germline copy number variation and cancer risk. Curr Opin Genet Dev 20((3):282-289.
• [65]Boland CR: Lynch syndrome: new tales from the crypt. Lancet Oncol 2012, 13(6):562-564.
• [66]Eckel-Passow JE, Atkinson EJ, Maharjan S, Kardia SL, De Andrade M: Software comparison for evaluating genomic copy number variation for Affymetrix 6.0 SNP array platform. BMC Bioinforma 2011, 12:220. BioMed Central Full Text
• [67]Tsuang DW, Millard SP, Ely B, Chi P, Wang K, Raskind WH, Kim S, Brkanac Z, Yu CE: The effect of algorithms on copy number variant detection. PLoS One 2010, 5(12):e14456.
• [68]Zhang D, Qian Y, Akula N, Alliey-Rodriguez N, Tang J, Gershon ES, Liu C: Accuracy of CNV Detection from GWAS Data. PLoS One 2011, 6(1):e14511.
• [69]Kim SY, Kim JH, Chung YJ: Effect of Combining Multiple CNV Defining Algorithms on the Reliability of CNV Calls from SNP Genotyping Data. Genomics Inform 2012, 10(3):194-199.
• [70]Xu Y, Peng B, Fu Y, Amos CI: Genome-wide algorithm for detecting CNV associations with diseases. BMC Bioinforma 2011, 12:331. BioMed Central Full Text